Notably, the upregulation of MRP1, P-gp, and BCRP in RCC patients has been observed, where these proteins function as efflux pumps that, aided by ATPase activity, actively expel chemotherapeutic drugs from cancer cells (Li et al., 2018; Long et al., 2015). Here, ABCC1 is linked to cancer.